Immunotope is Drug Discovery in United States that focus on chronic viral infections business. Founded in 2002. They cover business area such as developer, immunotherapy product, prevention, cancer, chronic viral infection, technology, successful immunotherapy, specificity, early detection, innovative tool, service, collaborative development, novel drug and diagnostic product, patient, effective treatment, tumor, metastasis.
2002
( 22 years old in 2024 )
Chronic Viral Infections
-
The Pennsylvania Biotechnology Center
3805 Old Easton Road
Doylestown, PA 18901
United States
Private
developerimmunotherapy productpreventioncancerchronic viral infectiontechnologysuccessful immunotherapyspecificityearly detectioninnovative toolservicecollaborative developmentnovel drug and diagnostic productpatienteffective treatmenttumormetastasis
* We use standard office opening hours in near Immunotope's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immunotope is Drug Discovery business from United States that founded in 2002 (22 years old in 2024), Immunotope business is focusing on Chronic Viral Infections.
Immunotope headquarter office and corporate office address is located in The Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 18901 United States.
Immunotope was founded in United States.
In 2024, Immunotope is currently focus on chronic viral infections sector.
Above is snippet of Google Trends for "chronic viral infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immunotope, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
